This topic contains a solution. Click here to go to the answer

Author Question: Relying on clinical findings for the treatment of ventilator-associated pneumonia may do which of ... (Read 54 times)

go.lag

  • Hero Member
  • *****
  • Posts: 667
Relying on clinical findings for the treatment of ventilator-associated pneumonia may do which of the following?
 
  a. Decrease the morbidity of VAP.
  b. Decrease the mortality of VAP.
  c. Create multidrug-resistant organisms.
  d. Reduce the need for invasive microbio-logic procedures.

Question 2

The initial empiric antibiotic used to treat suspected methicillin-resistant Staphylococcus aureus in a patient with late-onset VAP is which of the following?
 
  a. Linezolid
  b. Gentamicin
  c. Tobramycin
  d. Ciprofloxacin



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

isabelt_18

  • Sr. Member
  • ****
  • Posts: 342
Answer to Question 1

ANS: C
Relying on clinical findings alone can result in unnecessary use of broad-range antibiotics, which in turn can lead to the emergence of multidrug-resistant strains of microorganisms.

Answer to Question 2

ANS: A
According to Table 14-2, patients with late-onset VAP who develop MRSA should be treated with linezolid or vancomycin.





 

Did you know?

The training of an anesthesiologist typically requires four years of college, 4 years of medical school, 1 year of internship, and 3 years of residency.

Did you know?

It is important to read food labels and choose foods with low cholesterol and saturated trans fat. You should limit saturated fat to no higher than 6% of daily calories.

Did you know?

Immunoglobulin injections may give short-term protection against, or reduce severity of certain diseases. They help people who have an inherited problem making their own antibodies, or those who are having certain types of cancer treatments.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

Did you know?

People who have myopia, or nearsightedness, are not able to see objects at a distance but only up close. It occurs when the cornea is either curved too steeply, the eye is too long, or both. This condition is progressive and worsens with time. More than 100 million people in the United States are nearsighted, but only 20% of those are born with the condition. Diet, eye exercise, drug therapy, and corrective lenses can all help manage nearsightedness.

For a complete list of videos, visit our video library